Medicine and Dentistry
Autoantibodies
100%
Autoantigen
18%
Autoimmune Disease
18%
Autoimmunity
9%
B Cell
45%
B Lymphocyte Receptor
9%
Cancer
18%
Cancer Therapy
9%
Cell Compartment
9%
Cell Therapy
9%
Chimeric Antigen Receptor
9%
Chimeric Antigen Receptor T-Cell
27%
Clinical Trial
9%
Combination Therapy
9%
Cytokine
9%
Cytotoxicity
9%
Desmoglein 3
100%
Diseases
9%
Immunotherapy
9%
Memory B Cell
18%
Pemphigus vulgaris
100%
Plasmablast
9%
Spontaneous Remission
18%
T Cell
36%
T Cell Activation
9%
T Cell Proliferation
9%
T Cell Subset
9%
T Lymphocyte Receptor
100%
Immunology and Microbiology
Autoantibodies
100%
Autoantigen
22%
Autoimmune Disease
22%
Autoimmunity
11%
B Cell
55%
B-Cell Receptor
11%
CD19
11%
Chimeric Antigen Receptor
11%
Chimeric Antigen Receptor T-Cell
33%
Cytokine
11%
Cytotoxicity
11%
Experimental Model
11%
Immunotherapy
11%
Memory B Cell
22%
Pemphigus vulgaris
100%
Plasmablast
11%
T Cell
44%
T Cell Activation
11%
T Cell Proliferation
11%
T Cell Receptor
100%
T Cell Subset
11%
Pharmacology, Toxicology and Pharmaceutical Science
Autoantibodies
100%
Autoantigen
18%
Autoimmune Disease
18%
B Lymphocyte Receptor
9%
Chimeric Antigen Receptor
36%
Clinical Trial
9%
Combination Therapy
9%
Cytokine
9%
Cytotoxicity
9%
Desmoglein 3
100%
Diseases
9%
Immunotherapy
9%
Malignant Neoplasm
9%
Pemphigus vulgaris
100%
Remission
27%
T Lymphocyte Receptor
100%
Tolerability
9%